Research Article
Risk Factors for Drug Resistance in Epileptic Children with Age of Onset above Five Years: A Case-Control Study
Table 1
Characteristics of subjects in the case and control groups.
| Characteristics | Case | Control | Total |
| Sex | | | | Male | 11 (34.4%) | 11 (34.4%) | 22 (34.4%) | Female | 21 (65.6%) | 21 (65.6%) | 42 (65.6%) | Age (mean [SD] in months) | 143.72 (35.21) | 145.48 (32.87%) | | Age groups () | | | | >5–9 years | 6 (18.8%) | 6 (18.8%) | 12 (18.8%) | >9–14 years | 18 (56.2%) | 18 (56.2%) | 36 (56.2%) | >14 years | 8 (25.0%) | 8 (25.0%) | 16 (25.0%) | Age of onset (mean [SD] in months) | 92.19 (25.70) | 104.41 (31.51) | | Average number of drugs used | 3.19 | 1.09 | | Monotherapy | 30 (93.75%) | 0 (0%) | 30 (46.87%) | Polytherapy | 2 (6.25%) | 32 (100%) | 34 (53.13%) |
|
|
All comparisons between both groups were not statistically significant ( ) except for the number of drugs used ( ). |